40.40 - 41.05
29.80 - 47.18
2.12M / 3.66M (Avg.)
18.02 | 2.27
Shows the trajectory of a company's cash-generation capacity. Consistent growth in operating and free cash flow suggests a robust, self-funding business model—crucial for value investors seeking undervalued, cash-rich opportunities.
-66.50%
Negative net income growth while CRK stands at 229.97%. Joel Greenblatt would see a comparative disadvantage in bottom-line performance.
-0.85%
Both reduce yoy D&A, with CRK at -11.98%. Martin Whitman would suspect a lull in expansions or intangible additions for both.
89.98%
Lower deferred tax growth vs. CRK's 210.15%, implying fewer future tax liabilities. David Dodd would confirm there’s no short-term tax shock instead.
No Data
No Data available this quarter, please select a different quarter.
72.53%
Slight usage while CRK is negative at -81.85%. John Neff would note competitor possibly capturing more free cash unless expansions are needed here.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
72.53%
Growth of 72.53% while CRK is zero at 0.00%. Bruce Berkowitz would see a difference in minor WC usage that might affect short-term cash flow if large.
65.57%
Some yoy increase while CRK is negative at -61.93%. John Neff would see competitor possibly reining in intangible charges or revaluations more effectively than we do.
36.66%
Some CFO growth while CRK is negative at -7.07%. John Neff would note a short-term liquidity lead over the competitor.
-11.37%
Negative yoy CapEx while CRK is 79.25%. Joel Greenblatt would see a near-term FCF boost unless competitor invests for long-term advantage.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
-127.67%
Both yoy lines negative, with CRK at -100.08%. Martin Whitman suspects a cyclical or strategic rationale for cutting extra invests in the niche.
-447.60%
We reduce yoy invests while CRK stands at 26.81%. Joel Greenblatt sees near-term liquidity advantage unless competitor’s expansions yield high returns.
-70.02%
We cut debt repayment yoy while CRK is 0.00%. Joel Greenblatt sees competitor possibly lowering risk more if expansions do not hamper them.
2.34%
We slightly raise equity while CRK is negative at -86.18%. John Neff sees competitor possibly preserving share count or buying back shares.
50.69%
Buyback growth of 50.69% while CRK is zero at 0.00%. Bruce Berkowitz sees a modest per-share advantage that might accumulate if the stock is below intrinsic value.